New HIV shot shows promise in early trial
NCT ID NCT06560489
First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This study tested a new medicine called LP-98, given as multiple shots under the skin, in 40 adults with HIV who had not taken any HIV drugs before. The main goals were to check if the shots are safe and how they affect the virus and the body. The results will help decide if LP-98 can be a new way to control HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Provincial Hospital for Infectious Diseases (Zhengzhou Sixth People's Hospital)
Zhengzhou, Henan, China
Conditions
Explore the condition pages connected to this study.